Treatment with an uPAR (ATN 658) antibody inhibits ovarian cancer metastasis.

被引：0
|
作者：
Kenny, Hilary A. [1 ]
Jagadeeswaran, Sujatha [1 ]
Mazar, Andrew P. [2 ]
Lengyel, Ernst [1 ]
机构：
[1] Univ Chicago, Chicago, IL 60637 USA
[2] Attenuon LLC, San Diego, CA USA
来源：
MOLECULAR CANCER THERAPEUTICS | 2007年 / 6卷 / 12期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：3536S / 3536S
页数：1
相关论文
共 50 条
  • [21] The metabolic stress mediator LKB1 is required for ovarian cancer metastasis.
    Buensuceso, Adrian
    Valdes, Yudith R.
    Figueredo, Rene
    DiMattia, Gabriel E.
    Shepherd, Trevor G.
    CLINICAL CANCER RESEARCH, 2018, 24 (15) : 43 - 43
  • [22] Combination Niraparib and Metformin synergistically inhibits endometrial cancer cell growth and metastasis.
    Gan, Qiyu
    Cheng, Jingxin
    Chen, Rui
    Bie, Yachun
    Wang, Guozeng
    Chang, Linlin
    CANCER RESEARCH, 2021, 81 (13)
  • [23] Antibody treatment for ovarian cancer
    Liddle, Rachel
    LANCET ONCOLOGY, 2007, 8 (08): : 676 - 676
  • [24] Dihydroartiminisin inhibits the growth and metastasis of epithelial ovarian cancer
    Wu, Buchu
    Hu, Ke
    Li, Shu
    Zhu, Jing
    Gu, Liying
    Shen, Haoran
    Hambly, Brett D.
    Bao, Shisan
    Di, Wen
    ONCOLOGY REPORTS, 2012, 27 (01) : 101 - 108
  • [25] Neutralizing Monoclonal Antibody to Periostin Inhibits Ovarian Tumor Growth and Metastasis
    Zhu, Min
    Saxton, Romaine E.
    Ramos, Lillian
    Chang, David D.
    Karlan, Beth Y.
    Gasson, Judith C.
    Slamon, Dennis J.
    MOLECULAR CANCER THERAPEUTICS, 2011, 10 (08) : 1500 - 1508
  • [26] Nicotinamide N-methyltransferase metabolically reprograms the stroma to promote ovarian cancer metastasis.
    Eckert, Mark A.
    Coscia, Fabian
    Chryplewicz, Agnieszka
    Chang, Jae Won
    Pan, Shawn
    Tienda, Samantha M.
    Lastra, Ricardo R.
    Curtis, Marion
    Yamada, S. Diane
    McGregor, Stephanie M.
    Moellering, Raymond E.
    Mann, Matthias
    Lengyel, Ernst
    CLINICAL CANCER RESEARCH, 2018, 24 (15) : 30 - 30
  • [27] Ovarian preservation among women with early stage cervical cancer. A retrospective evaluation of the incidence of ovarian metastasis.
    Billod, Jimmy A.
    Domingo, Efren Javier
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [28] Computational methods and novel in vitro model elucidate a therapeutic target against ovarian cancer metastasis.
    Carroll, Molly J.
    Fogg, Kaitlin C.
    Patel, Harin A.
    Mancha, Anne-Sophie
    Patankar, Manish S.
    Kreeger, Pamela K.
    CLINICAL CANCER RESEARCH, 2018, 24 (15) : 48 - 49
  • [29] The prognostic significance of epidermal growth factor receptor (EGFR) expression in ovarian cancer (OC) metastasis.
    Rahaman, J
    Nagarsheth, N
    Nezhat, F
    Cohen, C
    Kalir, T
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 471S - 471S
  • [30] Galunisertib inhibits ovarian cancer cell fibrosis and metastasis in vitro
    Zhang, Qing
    Cliby, William A.
    CANCER RESEARCH, 2016, 76
12345